Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.


Although antidepressants are widely used in the pharmacotherapy of major depressive disorder (MDD), their efficacy is still insufficient as approximately one-third of the patients do not fully recover even after several treatment trials. Inter-individual genetic differences are thought to contribute to the variability in antidepressant response; however… (More)
DOI: 10.1177/0269881113499829

4 Figures and Tables


  • Presentations referencing similar topics